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ABSTRACT: Nature’s motors are complex and eﬃcient systems,
which are able to respond to many diﬀerent stimuli present in the
cell. Nanomotors for biomedical applications are designed to mimic
nature’s complexity; however, they usually lack biocompatibility and
the ability to adapt to their environment. Polymeric vesicles can
overcome these problems due to the soft and ﬂexible nature of
polymers. Herein we will highlight the recent progress and the crucial
steps needed to fabricate active and adaptive motor systems for their
use in biomedical applications and our approach to reach this goal.
This includes the formation of active, asymmetric vesicles and the
incorporation of a catalyst, together with their potential in biological
applications and the challenges still to overcome.
1. INTRODUCTION
Biological motors, such as ribosomes,1 kinesins,2 and ATP
synthase,3 are essential natural machines that perform their
functions with supreme eﬃciency. Many scientists have tried to
understand and mimic these structures by creating various
synthetic micro- and nanosized motors, in particular those that
lead to translational motion. Combining structural design with
motion has led to many successful constructs, such as
molecular motors,4−6 switches,7 ratchets,8 bimetallic nano-
rods,9−13 Janus capsules,14,15 and shuttles.16,17 The speciﬁc
requirements of each motor depend on their application and
functional design, yet, asymmetry plays an important role in
the design, together with the incorporation of a catalyst that
can convert chemical energy into motion. To mimic biological
motors, the system should be adaptive and made from soft and
biodegradable materials. This ensures that the motor can feel
its environment and respond accordingly, so that it is able to
actively perform the task it was designed for. So far, the
majority of research has focused on creating artiﬁcial motors
that are based on metal catalysts or metal surfaces and are
therefore not compatible for biomedical applications. The
challenge is to design nanomotors made of soft materials,
which are adaptive and fully biocompatible and/or biodegrad-
able. Therefore, it is necessary to consider not only the
structural design but also the construction approach.
The two main approaches for the formation of micro- and
nanostructures are top-down and bottom-up, although,
increasingly hybrid methods are used as well, which combine
advantages of both methods. With the top-down approach,
larger structures or patterns are reduced to nanoscale
dimensions. The methods that are mostly used are subtractive
and additive lithography techniques, such as etching, electro-
deposition, and sputtering, or molding processes, such as
PDMS printing. Fabrication using a top-down approach is
straightforward and cheap; however, the scale up production is
diﬃcult to achieve and it faces size limitations when going for
even smaller designs. The ﬁrst nano- and micromotors have
been created using these techniques.18−21 The bottom-up
approach starts with molecular building blocks that are used to
build up the ﬁnal structure, often involving synthesis or self-
assembly. The bottom-up approach is more versatile in design
and choice of materials. With this method the smallest
structures can be made, for instance the well-known molecular
motors from the Feringa group.22−24 Lately, several examples
of nanomotors are published that combine the top-down and
bottom-up approach, such as the fabrication of ordered arrays
of functional nanotubes,25 directed self-assembly of polymers
by patterned templates,26 and layer-by-layer deposition to form
multilayer Janus capsules.27
However, limited examples exist of motors created solely by
bottom-up approaches.28,29 Our lab has reported bottom-up
self-assembly of micro- and nanomotors from diﬀerent
polymers.17,30−33 The supramolecular approach to develop
nanomotor carriers for biomedical applications is the main
inspiration for our group. Designing soft, biocompatible
carriers has a wide range of implications, not only from the
applications point of view, but also from the perspective of
mimicking and consequent understanding of such fascinating
structures. In this Perspective, the supramolecular paths to
form asymmetric morphologies are discussed that form the
foundation of our self-propelling structures. In the following
subsections, we focus on the development of asymmetric
structures into nanomotors by incorporating a catalyst and
their potentials for biomedical applications by showing their
adaptive abilities, cellular uptake and release of drug molecules.
Comprehensive reviews focused on nano- and micromotors
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and their applications,34−36 molecular motors,37,38 and on
nanoreactors39−41 and will not be discussed here. Instead, we
speciﬁcally focus on self-assembled polymeric motors and our
approach from fabrication to application.
2. SHAPE
The ﬁrst factor to consider while designing autonomous
particles is their shape. Asymmetry, either in catalyst
distribution or in shape, is required to obtain autonomous
motion. Here we focus on the design of asymmetric shapes for
our micro- and nanomotor.
Polymersomes are bilayered polymeric vesicles made from
amphiphilic block copolymers comprising hydrophobic and
hydrophilic covalently linked chains (Figure 1A,B). In aqueous
media, these block copolymers spontaneously self-assemble
into spherical vesicles (Figure 1C).17,30 Thereby, three
diﬀerent compartments are created; an inner aqueous lumen,
a hydrophobic membrane and a hydrophilic outer surface.
During polymersome formation, cargo can be captured inside
the lumen, which is shielded from potentially unfavorable
environments in biological settings.30,42 This allows the
formation of nanocarriers or nanoreactors for various
applications, such as drug delivery,43 imaging44 or mimics of
life-like systems.45 Polymersomes show increased stability and
membrane integrity compared to liposomes, due to their
relatively thick membrane and are therefore used as alternative
carriers.17,32 While a thick membrane allows them to tolerate
changes in the environment, their morphology can be re-
engineered and reshaped upon diﬀerent stimuli. The shape
transformation of spherical polymersomes in response to
various external stimuli, such as pH,46,47 osmotic pressure,48,49
temperature,50,51 chemical composition of the membrane52,53
and magnetic ﬁelds54,55 has been studied. Yet, it is important to
highlight that the polymersome properties, i.e., size, surface
charge, rigidity, and permeability, depend on their building
blocks.56−58 For the hydrophilic part of the block copolymer
often poly(ethylene glycol) (PEG) is implemented, due to its
stealth-like behavior. Although PEG is not biodegradable, it is
proven to be biocompatible.59,60 As hydrophobic block, various
polymers have been used,61−63 i.e., polybutadiene (PBD),64
polystyrene (PS),65 poly(ε-caprolactone) (PCL),66 and
polylactide (PLA),67 depending on their application. For
instance, polybutadiene has a glass transition temperature (Tg)
below room temperature, which makes the polymersomes
quite ﬂexible and suitable for drug release. On the other hand,
polystyrene has a high Tg, which creates a rigid amorphous
membrane when the organic solvent is removed, due to tight
packing of the benzene rings (Figure 1A).68 These character-
istics are useful for shape transformation of polymersomes, as
diﬀerent (intermediate) morphologies can be obtained.
However, neither polybutadiene nor polystyrene are biode-
gradable, so for biomedical applications alternatives are
required. Polylactide is a good candidate, as it is biodegradable
and has comparable properties to polystyrene, i.e., a relatively
high Tg and similar Hildebrand solubility parameters (Figure
1B).
Creating various shapes from spherical polymersomes is
exciting and important for many diﬀerent applications.
Therefore, understanding the fundamentals of the shape
transformations is key. Spherical polymersomes can deﬂate
via two distinct pathways deﬁning the ﬁnal morphology;
prolates (rod-like structures) or oblates (disc-like structures)49
(Figure 1D). The out-of-equilibrium situations that forces
spherical polymersomes to deﬂate into diﬀerent morphological
Figure 1. Synthesis and self-assembly of block copolymers. (A) Synthesis of poly(ethylene glycol)-polystyrene via atom transfer radical
polymerization (ATRP). (A) Synthesis of poly(ethylene glycol)-b-poly(D,L-lactide) via ring opening polymerization (ROP). (C) Self-assembly of
amphiphilic block copolymers in organic solvent by addition of water. (D) Shape transformation pathways of spherical polymersomes. Deﬂation
occurs via prolate or oblate structures. Dashed arrows represent the axis of symmetry.
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structures can be explained in terms of bending energy (eq
1).49,69
∮= −E k C C A2 (2 ) db 0 2 (1)
In this equation k is the bending rigidity constant (which
depends on material properties), C is the mean surface
curvature, and C0 stands for the spontaneous surface curvature.
When an external stimulus is applied to a ﬂexible membrane, a
positive or negative surface curvature is induced, thereby
inﬂuencing the bending energy. A positive bending energy will
lead to the formation of prolate morphologies, whereas a
negative bending energy leads to the formation of oblate
morphologies. The hydrophilic and hydrophobic parts of the
polymersome largely inﬂuence the surface charge, temperature
sensitivity, rigidity and permeability and thereby aﬀect the
shape change process.56−58 For example, introducing an
osmotic shock to spherical poly(ethylene glycol)-b-poly(D,L-
lactide) (PEG-b-PDLLA) polymersomes allows shape trans-
formation into elongated nanotubes (prolates), whereas
poly(ethylene glycol)-polystyrene (PEG-b-PS) showed stoma-
tocyte morphologies (oblates) under similar conditions.48,49
However, careful tuning of the conditions makes it possible to
create nanorods and nanotubes of PEG-b-PS49 or stomatocytes
of PEG-b-PDLLA.70 By adding high amounts of PEG (Mw
2000) to spherical polymersomes it is even possible to create
stomatocyte in stomatocyte structures.71 The ﬁnal shape is not
only important for their function but also for their application
and communication to the environment. For example,
structures with high aspect ratio have more interaction sites,
leading to enhanced particle uptake by cells through
multivalency.72
Polymersomes assembled from PEG-b-PS have a ﬂexible and
responsive bilayer membrane in the presence of plasticizing
organic solvents and are rigid and nonresponsive in water due
to the tightly packed glassy hydrophobic polystyrene blocks in
their membranes. Once the plasticizing solvent is completely
removed, the kinetically driven process of membrane folding
stops due to vitriﬁcation of the membrane. The shape
transformation can therefore also be stopped at any moment
during the shape transformation process by adding excess of
water, quenching the (intermediate) structures and forcing the
system in a kinetically trapped state.73 These properties
enabled the shape transformation of spherical vesicles into
bowl-shaped stomatocytes via disc morphologies by dialyzing
against water (Figure 1D).30 However, small amounts of
organic solvents or additives in the sample leave the membrane
slightly ﬂexible and permeable, allowing solvent exchange from
the inner lumen and outside environment. This can result in a
metastable conﬁguration, where the system slowly relaxes to a
more stable conﬁguration.73 For instance, spherical PEG-PS
polymersomes can deﬂate in a mixture of water and organic
solvent to prolate structures and subsequently inﬂate back to
spheres after multiple days. By adding 50% (v/v) water, a slight
osmotic pressure is generated over the spherical polymer-
somes, causing an outﬂow of organic solvent. The polymer-
somes will form a prolate morphology to lower the osmotic
pressure at the expense of the bending energy. When the
organic solvent is not removed, it acts as plasticizer, allowing
water to ﬂow back in slowly, relieving the bending energy. This
results in the inﬂation of the prolates to the more stable
spherical polymersomes.49
The method in which the organic solvent is removed
completely, is named the “solvent switch” method, as the
plasticizing solvent is switched for water, rigidifying the ﬁnal
polymersome morphology. Another approach is the “reverse
addition” method, in which glassy stomatocytes are reversibly
plasticized and made ﬂexible when dialyzed in a mixture of
organic solvent and water.30 Depending on the time of
exposure to the plasticizer, diﬀerent morphologies are
obtained, such as ellipsoids and kippah structures.74 When
the same reverse dialysis method was applied to rigid glassy
polymersomes, stomatocyte morphologies were obtained with
diﬀerent sizes of their openings, depending on the time of
dialysis and the mixture and composition of water and organic
solvent.42 The desired morphologies could also be quenched
by vitrifying the membrane in water, allowing reshaping of
existing polymersome morphologies. The drawback of this
method, however, is the limited control in the size of the
opening of the stomatocytes due to the increased ﬂexibility of
the membrane during the reverse dialysis. A third method was
developed to provide a mild methodology for shape trans-
Figure 2. (A) Microﬂuidic design for the generation of droplet-in-droplet morphologies of poly(ethylene glycol) diacrylate (PEGDA) and dextran.
The dextran phase templates the asymmetric shape, upon polymerization of PEGDA it will partly diﬀuse inside the gel resulting in a rough inner
surface. (B) Cryo-scanning electron microscopy (cryo-SEM) image of the microparticle showing the rough inner surface. Scale bar corresponds to
10 μm. Reproduced from ref 33 with permission from John Wiley and Sons. Copyright 2018 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim.
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formation in biological setting for encapsulation of proteins
and enzymes. Large amounts of solvent can damage these
complex structures, as will be discussed in later sections, thus
the “solvent addition” method was introduced.42 In this
method, small amounts of solvent are added to spherical PEG-
PS polymersomes to introduce shape transformation based on
fast osmotic stress generation over the glassy PS membrane.
Upon addition of less than 25% (v/v) of solvent, a shape
transformation from spherical polymersomes to large opening
stomatocytes was observed. Adding more aliquots led to a
decrease of the stomatocyte neck size, to the extent that
virtually closed stomatocytes were obtained. At any stage of
this cycle, organic solvent could be removed and water could
be added to capture the stomatocyte structure with controlled
opening. The stomatocyte structure provides both asymmetry
as well as a protected inner cavity, thus oﬀering a lot of
interesting possibilities, especially for nanomotors or nano-
reactor applications.
Recently, we designed a micromotor to mimic the
stomatocyte shape at the microscale.33 Because such micro-
sized particles are easier to visualize, we hoped to learn more
about their behavior and correlate this to the nanoscale.
Although this is a nice strategy to mimic the shape of the
stomatocyte nanoparticles, the microparticle is made from a
completely diﬀerent material; a cross-linked gel. The formation
of asymmetric particles is based on the phase separation of two
polymeric solutions, which are poly(ethylene glycol)diacrylate
(PEGDA) and dextran. In a microﬂuidic chip, a droplet-in-
droplet system is generated containing dextran in PEGDA in
oil, which is the continuous phase and ensures emulsiﬁcation
of the PEGDA/dextran droplets. After collection from the
chip, the PEGDA phase can be speciﬁcally polymerized due to
the diacrylate functionality. The dextran phase is added as a
template to provide the asymmetry in the particle. Upon
polymerization of PEGDA, it will partly diﬀuse inside the gel
and ensures a rough inner surface (Figure 2).
In the section below, the incorporation of a catalyst in the
stomatocytes is described, including a metal catalyst, which
decomposes hydrogen peroxide into water and propelling
oxygen, and an enzyme couple catalyst that uses glucose as
fuel.
3. AUTONOMOUS SYSTEMS
The ﬁrst stomatocyte nanomotors were created by the
encapsulation of platinum nanoparticles inside their cavity
during the shape transformation via a process called “artiﬁcial
endocytosis”.30 Interestingly, when large particles (100 nm)
were used for encapsulation, size and shape of the stomatocyte
cavity were accordingly aﬀected due to a possible templating
eﬀect from the particle. Platinum is a known catalyst for the
decomposition reaction of hydrogen peroxide into water and
oxygen, which can escape through the opening of the
stomatocytes, propelling it forward. The state-of-art design
was conceptually an important milestone for developing new
stomatocyte biohybrid motors, using enzymes instead of
platinum as engines and utilizing biofuels instead of hydrogen
peroxide for propulsion. For this purpose, the “solvent
addition” methodology was developed to protect the enzymes
from denaturation. Enzymes were ﬁrst mixed with open neck
stomatocytes and subsequently, the neck was closed by adding
small amounts of organic solvent. This process led to the
encapsulation of the enzymes while their denaturation was
prevented, forming a hybrid polymeric supramolecular nano-
motor (Figure 3).42 We encapsulated the well-known enzyme
cascade glucose oxidase (GOx) and catalase (Cat) in the
stomatocytes to break down glucose. GOx catalyzes the
oxidation of glucose to gluconolactone and H2O2, which is
decomposed by Cat into water and propelling oxygen. The
stomatocytes encapsulating both enzymes showed propulsion
at biological relevant glucose concentration (5 mM) and
continued moving in the presence of trypsin, a proteolytic
enzyme known to inhibit enzymes activity.
4. ADAPTIVE NANOMOTORS
The next step, a far more challenging task, is to make adaptive
systems that can interact and respond to their environment.
Earlier attempts to achieve this adaptability by control over
motion included disassembly of the complete system75 and
chemical inhibition of the catalytic process,76 which led to the
complete loss of motion without the possibility of restarting.
Inhibition of the catalytic process involves adding more
chemicals to the system, increasing complexity and decreasing
Figure 3. (A) Incorporation of enzymes inside the stomatocyte cavity. Encapsulation is performed under mild conditions to minimize contact of
the enzymes with organic solvent. Small amounts of organic solvent are added to form and close the opening of the stomatocyte. When fuel is
added, the entrapped enzymes produce water and oxygen to propel the nanomotor forward. (B) Cryo-transmission electron microscopy (cryo-
TEM) pictures of spherical polymersomes, open and closed stomatocytes. Scale bars correspond to 200 nm. (C) TEM coupled with energy
dispersive X-ray spectroscopy (EDX) showing the mapping of iron (Fe) and sulfur (S), speciﬁc for enzymes and the localization inside the
stomatocyte cavity. Adapted with permission from ref 42. Copyright 2016 American Chemical Society.
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biocompatibility. Restarting the motor means getting rid of all
the chemicals added for inhibition, which is time-consuming
and in biological context not possible. With this in mind,
ﬁnding a method to incorporate the ability for nanomotors to
respond to its environment without altering its structure or its
catalytic activity remains a challenging task. Here we discuss
our attempts to make adaptive systems by gaining control over
motion and directionality.
4.1. Control over Motion. Our strategy to gain control
over motion is by incorporating stimuli responsive units onto
the stomatocytes opening, which allows reversible opening and
closing of the “molecular valve” upon, for example, a
temperature stimulus. This will lead to a cut oﬀ of the fuel
supply and thus stop the motor from moving autonomously.
This motion-controlled system is based on the integration of a
temperature-responsive poly(N-isopropylacrylamide) (PNI-
Figure 4. Schematic overview of adaptive supramolecular nanomotor systems. (A) Temperature-responsive poly(N-isopropylacrylamide) PNIPAM
brush as reversible brake. At 30 °C, the PNIPAM is hydrophilic, allowing access of fuel to the stomatocyte cavity; however, at 40 °C the PNIPAM
becomes hydrophobic, which induces a collapsed state denying access to fuel and ceasing nanomotor motion. Adapted by permission from Springer
Nature, ref 77. Copyright 2017 Macmillan Publishers Limited, https://www.nature.com/nchem/. (B) Because of the chemotactic nature of the
nanomotors, they move toward higher concentration of fuel. The graph left shows highly directional motion along the fuel gradient, while the graph
right in absence of fuel shows no directionality at all. Adapted from ref 83 with permission from John Wiley and Sons. Copyright 2015 The
Authors. Published by Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim. (C top) A gradient magnetic ﬁeld can induce magnetotaxis along the
magnetic gradient. At position 0, 1 cm away from the magnet, motion and directionality increased in comparison to position 1, 3, 5 cm away from
the magnet; however, at position 1 with added H2O2 speeds increased with respect to the second graph. (C bottom) Homogeneous magnetic ﬁelds
were used to navigate nanomotors in the presence of fuel. Images 1 to 4 show that they can be guided along a distinct path. Adapted from ref 87
with permission from John Wiley and Sons. Copyright 2016 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim. (D) Sustained motion was
obtained by encapsulating a enzymatic network inside stomatocytes, which is shown in the middle. The graph below shows that the speed was
constant over time and thus not dependent on fuel concentration. Adapted with permission from ref 88. Copyright 2016 American Chemical
Society.
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PAM) brush onto the stomatocyte nanomotor surface that was
grown onto the motor’s surface using surface-initiated atom
transfer radical polymerization (SI-ATRP).77 PNIPAM is a
temperature-responsive polymer with a lower critical solution
temperature (LCST) of around 35 °C.78 Above this LCST,
PNIPAM undergoes a transformation from hydrophilic to
hydrophobic that leads to a collapsed, coiled state of the
polymer, forming a hydrophobic layer on top of the
stomatocyte opening. The hydrophobic layer prevents access
of the fuel to the nanomotor cavity, thereby ceasing their
propulsion (Figure 4A). Turning the motor “on” and “oﬀ” is
completely reversible and does not aﬀect the motion behavior
signiﬁcantly. PNIPAM functionalized nanomotors exhibit only
slightly lower speeds than the nonfunctionalized nanomotors.
This might be due to its increased size or decreased diﬀusion
through the PNIPAM brush, which lowers the access of fuel
inside the nanomotor even in its hydrophilic state. At higher
temperatures, however, the propulsion diminished to a level
that is almost as low as Brownian motion indicating successful
functioning of the thermoresponsive brake system.
4.2. Control over Directionality. While achieving control
over the motion is crucial for autonomous complex systems,
control over directionality is of great signiﬁcance especially for
potential biomedical applications. An example is active drug
delivery toward tumor cells that overproduce signaling
molecules, i.e., hydrogen peroxide, that fuel the motion of
the motor.79 Excellent research has shown directional control
of nano/micromotors by guiding them to the desired locations.
Such a control is usually a response of the motors toward
external stimulus such as temperature,80 light,81 concentration
gradients,82,83 and magnetic ﬁelds.84
Again, nature is a great inspiration when it comes to
directional movement. Bacteria, amoebas, and neutrophils
sense substrate concentration gradients and accordingly
navigate toward them.85 Scientists have shown chemotaxis of
various motors82 or even single enzymes.86 Chemotactic
behavior toward high fuel concentration was also observed
for the platinum loaded stomatocytes.83 Diﬀerent models were
used to study the chemotactic behavior of platinum loaded
stomatocytes, including static, dynamic and cell models. In the
static and dynamic ﬂuidic models, directionality toward higher
fuel concentrations was observed even at concentrations as low
as 0.5% hydrogen peroxide. The nanomotors showed chemo-
tactic behavior along the fuel gradient as well as increased
velocities at higher concentrations. Hydrogen peroxide
excreting neutrophils were used as cell-model. Neutrophils in
cell culture substrate were placed in the middle of a Petri dish
containing a nanomotor solution. The nanomotors showed
directional movement toward the hydrogen peroxide excreting
cells. A decrease in directionality and speed was observed for
positions further away from the fuel source (Figure 4B). It was
hypothesized that the chemotactic directional control in
movement was due to nanomotors developing higher speeds
at higher fuel concentrations, thus traveling longer distances.
Another method to control motion is by the use of external
magnetic ﬁelds, which allows a long-range directional control.
Nickel loaded nanomotors are susceptible to magnetic ﬁelds
due to their ferromagnetic behavior resulting in magneto-
taxis.87 Magnetic locomotion can be achieved by magnetic
gradients while homogeneous ﬁelds can be used as navigation
in the presence of fuel (Figure 4C). A gradient is established
by using only one NdFeB magnet at the desired location,
whereas homogeneous magnetic ﬁelds are applied by
sandwiching the sample in between two magnets. Nanomotors
encapsulating both platinum and nickel are catalytically
powered in the presence of hydrogen peroxide as well as
magnetic ﬁeld and can be operated in dual propulsion mode.
Adding hydrogen peroxide in combination with the magnetic
gradient resulted in increased velocity and directionality.
Magnetic locomotion is thus possible using magnetic gradients
and can be enhanced by adding fuel. A collagen network
loaded with HeLa cells was used as a tissue mimic to test
transportation abilities of the nanomotors using magnetic
locomotion. The nanomotors were guided through the gel
network toward a cell via the magnetic gradient. Removing the
homogeneous magnetic ﬁeld resulted in dispersive movement.
4.3. Adaptive System with Feedback Control. The
nanomotors based on platinum nanoparticles and the GOx/
Cat cascade were relatively simple nanomotor systems and an
early attempt to increase biocompatibility. However, biological
systems are using metabolic pathways, out-of-equilibrium
enzymatic networks with integrated feedback loops, which
allow adaptation in response to changes in the environment.
We have implemented this bioinspired concept and incorpo-
rated an entire glycolysis inspired metabolic pathway inside the
stomatocytes to generate adaptive nanomotors with sustained
autonomous movement.88 This system can sense and adapt to
the chemical environment and the presence of available fuel.
An enzymatic reaction network that is able to convert
naturally present substrates into molecular oxygen was
rationally designed. This enzymatic network consists of four
metabolic modules, working together for tunable and sustained
output. The ﬁrst “activation module” acts as activation and
regulation of the enzyme cycles by the conversion of ATP. The
next cycle is responsible for the generation of β-nicotinamide
adenine dinucleotide (β-NADH), which is consumed in the
third cycle to produce hydrogen peroxide. Finally, the last cycle
containing Cat will decompose hydrogen peroxide into water
and oxygen and is thus the motor of the system. This
enzymatic reaction network was encapsulated in the cavity of
PEG-PS stomatocytes and their motion was further analyzed in
the presence of glucose as fuel. At 10 mM glucose, the motors
speed output stayed constant even after 180 min, highlighting
the ability of this network in sustaining its output through
extended periods of time by regulating fuel consumption
(Figure 4D). The network output was also tuned by changing
ATP concentration, because ATP determines the concen-
tration of β-NADH and thus the consequent hydrogen
peroxide production. The capability of this enzymatic network
to maintain a ﬁxed motor speed output during glucose
consumption and the possibility of tuning this output by
controlling the speed of certain cycles in the network is unique
and advantageous.
In this case, the protective element and the conﬁnement
eﬀect of the stomatocyte nanomotor was highlighted by
showing its functioning in complex media, human blood serum
(HBS). HBS contains many diﬀerent proteins and enzymes,
among which is catalase. When hydrogen peroxide is not
produced in the cavity, but in bulk, it is converted by free
catalase present in the medium. As a result, the hydrogen
peroxide concentration is lowered to such an extent that the
entrapped catalase cannot induce any propulsion anymore. In
HBS, motion of stomatocytes was maintained and was
unaﬀected by the media. This is an important aspect when
considering the use of this system in biological context.
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5. BIOMEDICAL APPLICATIONS
Many of the nanomotor designs have been developed with the
idea of using them for biomedical applications, such as drug
delivery,15,83 organelle mimics,89−91 and cargo transporters in
medical devices.92,93 One of the greatest challenge is, however,
the realization of a nanometer scale transporter with controlled
size, shape, and suitable design to facilitate these applications.
In particular, the biodegradability and biocompatibility of the
transporter as well as the available fuels in biological systems.
Furthermore, the nanostructures should be able to capture
cargo, transport and release it at the desired location, which
desirably would be inside cells for drug delivery purposes. We
already discussed the formation of biocompatible/degradable
structures, catalysts and fuels. The next step is to translate this
to biomedical applications, for which the motors should be
able to release cargo and to actively ﬁnd the desired location.
5.1. Release of Cargo. A hydrophilic cargo drug can be
captured inside the hydrophilic core of the polymersomes, after
which it can be transformed into a nanomotor carrying this
cargo in the inner compartment. To be able to release this
cargo, the nanomotor membrane should be degradable. This
can be done by incorporating biodegradable building blocks
such as PCL as hydrophobic part to make mixed PEG-PCL/
PEG-PS stomatocyte structures. Incorporation of up to 75%
PEG-b-PCL maintained the stomatocyte morphology and did
not aﬀect the speed of the motor.66 The PEG-b-PCL formed
domains in the bilayer vesicle at percentages higher than 50%
due to its semicrystallinity. This is advantageous, because PCL
degrades at low pH, and resulted in the formation of large
pores in the stomatocytes, which enabled release of cargo.
Higher percentages of PCL showed increased release of cargo
at pH 5 (Figure 5A). In vitro experiments showed that
particles were taken up by HeLa cells and subsequently
released their cargo as a response to the local low pH
environment. The reference sample, consisting of non-
biodegradable PEG-PS nanomotors, did not release their
cargo as can be seen by the presence of ﬂuorescent spots
instead of the homogeneously spread doxorubicin with the
partly biodegradable system.94 The same was observed for
nanomotors having a disulﬁde bridge in between the
hydrophilic and hydrophobic part of the polymers.95 In the
presence of reducing agent glutathione, which is also present in
cells, the nanomotors cease their motion and release the drug
upon complete destruction of their structure. In vitro, this
resulted in a homogeneous diﬀusion of doxorubicin for the
degradable motors, while the motors lacking the disulﬁde
bridge were staying intact.
Another approach to release cargo is not by destroying the
stomatocytes, but by changing their morphology, which leads
to a release of cargo. The cargo is in this case not loaded in the
inner polymersome core, but inside the stomatocyte cavity.
Here, the cargo is in contact with the outer environment and
can be released by opening the stomatocyte neck. Manipu-
lation of the shape can be done by magnetic ﬁelds, because
polystyrene is diamagnetic and it has a high anisotropic
susceptibility in high magnetic ﬁelds.54 When a magnetic ﬁeld
was applied to a stomatocyte solution containing a plasticizing
organic solvent, a deformation was observed from an overall
spherical stomatocyte structure to an elongated stomatocyte.
Such a deformation is a result of the phenyl groups present in
the PS backbone, which has a preference to align perpendicular
to the applied magnetic ﬁeld. Upon applying a magnetic ﬁeld,
ﬁrst, the stomatocytes aligned because of the anisotropic
distribution of the polymer orientations. Subsequently, the
polymers itself aligned perpendicular to the magnetic ﬁeld,
inducing a change in morphology. This alignment resulted in a
Figure 5. (A) Biodegradable hybrid nanomotor system, stomatocytes made from mixture of PEG-PCL and PEG-PS. (i) Cryo-SEM image of
nonbiodegradable PEG-PS stomatocytes. (ii) Cryo-SEM image of hybrid biodegradable PEG-PS:PEG-PCL stomatocytes after pore formation. The
bottom graph shows increased release of cargo for vesicles that have a higher percentage of PEG-PCL at low pH. Adapted with permission from ref
66. Copyright 2017 American Chemical Society. (B) Stomatocyte functionalized with cell penetration tat-peptide. Fluorescent and bright-ﬁeld
image of cell uptake for nonactive (i) and active (ii) particles and nonactive tat-functionalized (iii) and active tat-functionalized (iv) particles and
the corresponding graph showing ﬂuorescent intensity. Active tat-functionalized particles showed increased uptake over nonactive
nonfunctionalized particles. Adapted with permission from ref 94. Copyright 2017 The Royal Society of Chemistry. (C) Polymersome
nanomotors show enhanced EPR eﬀect. Fluorescent confocal z-stacks show accumulation of active particles in the hydrogen peroxide rich bottom
chamber, while this is to a lesser extent with water or with nonactive particles. Adapted from ref 97 with permission from John Wiley and Sons.
Copyright 2018 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim.
Biomacromolecules Perspective
DOI: 10.1021/acs.biomac.8b01673
Biomacromolecules 2019, 20, 1135−1145
1141
more stretched, elongated morphology and opened up the
neck. The morphological change is completely reversible and
dependent on the magnetic ﬁeld strength, stronger ﬁelds result
in a larger opening. This method allows for cargo to be
captured and released at will and results in a more subtle
release than the destruction of the whole system. However, the
drawback of this system is the use of high magnetic ﬁelds.
5.3. Active Delivery. The next step is to obtain active
delivery of the cargo to the desired location. Despite the
disadvantages, the vast majority of drug delivery vehicles and
their research is focused on passive delivery, which is slow and
nonspeciﬁc. Enhanced uptake was already observed for
nonfunctionalized active particles (nanomotors in the presence
of fuel) compared to nonactive particles (nanomotors without
fuel) due to a higher chance of interaction (Figure 5Bi-ii). We
functionalized stomatocyte nanomotors with a cell penetrating
peptide, trans-activator of transcription (tat),94 which ensured
active uptake of our nanomotors into the cells. Cell
experiments showed enhanced uptake of tat-functionalized
nanomotors compared to nonfunctionalized nanomotors, due
not only to their cell penetrating abilities but also to their
associated motion (Figure 5Biii-iv). Having both an active
system as well as an active uptake mechanism will result in fast
and eﬃcient cell penetration. This approach will ensure uptake
into cells, yet, reaching the diseased cells is a diﬀerent problem.
Until now, drug delivery is mostly passive utilizing the
enhanced permeation and retention (EPR) eﬀect. This eﬀect
is a result of the leaky blood vessels around a tumor which
enhances the entry and accumulation of nutrients as well as
drugs.96 We investigated an enhanced EPR eﬀect to reach
cancer tissue by the exploitation of the nanomotors chemo-
tactic behavior toward higher fuel concentrations,97 as
explained earlier. A model was made from a double-layer
microslide consisting of an upper and bottom chamber
separated by a porous membrane seeded with endothelial
cells. The upper chamber was ﬁlled with nanomotors based on
polymersomes having a platinum patch, while the bottom
chamber was ﬁlled with either hydrogen peroxide or water. In
the presence of hydrogen peroxide, the nanomotors accumu-
lated twice as fast in the bottom chamber than in the presence
of water. This shows that using motors as drug delivery system
can result in an enhanced accumulation of the drug inside the
tumor.
6. CONCLUSIONS AND FUTURE PERSPECTIVES
In this Perspective, we highlighted the crucial steps to fabricate
active and adaptive locomotive systems for the use in
biomedical applications and our approach to reach this goal.
These include asymmetry, which is required for the formation
of motors and can be obtained by the self-assembly of diﬀerent
amphiphilic block copolymers into diﬀerent shapes, and the
incorporation of enzymes or other catalysts that transforms
passive vesicles into autonomous motors. We succeeded in
gaining control over motion, directionality and speed and
explored the possibilities of drug release and active targeting.
We showed that self-assembled autonomous particles are not
only capable of carrying a cargo but also move directionally in
the presence of a gradient of signaling molecules produced by
cells, transporting thus actively the cargo toward the cells
producing fuel. Additionally the supramolecular nanomortors
are interacting diﬀerently with cells compared with passive
particles and are taking up faster. While blood provides good
circulation of the nanocarriers at elevated speeds regardless if
they are passive or active, it is the interstitial tissue where
locomotive particles can help to facilitate crossing of the last
barriers, which is a challenge in current delivery applications.
Additionally, supramolecular nanomorors were demonstrated
to facilitate enhanced EPR eﬀect, spreading faster toward the
signaling molecules compared to passive carriers.
Despite all the progress in the micro and nanomotor ﬁeld
during the past years, there are still challenges to overcome and
questions to be answered, both regarding their mechanism of
motion and movement in crowded environment but also
toward their feasibility for applications in the biomedical ﬁeld.
This goal is coming slowly closer; however, most of the
nanomotor systems are not at all or only partly biocompatible,
utilizing toxic fuels for propulsion. The challenge is thus to
construct fully biocompatible and biodegradable motors that
can move directionally via chemotaxis in complex and crowded
biological environments and at biological relevant fuel
concentrations which are much lower than what has been
studied so far. Another challenge is to have all these
functionalities combined in one active delivery system while
moving in biological ﬂuids. Until now, most research has been
done in water or buﬀer. However, bodily ﬂuids have a complex
composition of many diﬀerent substituents that will aﬀect
motion but could also aﬀect other functionalities such as
targeting.
Another question that remains is a more fundamental one.
What is the exact underlying mechanism of motion and how
can we control the motion, directionality, and speed at the
nanoscale in complex environments? This depends on diﬀerent
aspects of the motors, such as size and the materials it is made
of. This is an experimentally diﬃcult question when dealing
with nanomotors, because most of the analysis techniques,
such as light scattering, are indirect. This challenge makes it
even more interesting to answer this question. When the
mechanism of motion is clear and completely understood, we
can more easily manipulate the system and this will help
overcome challenges and reach goals that are still ahead. The
recently published hydrogel micromotors from our group will
be used for this goal, to gain more insight in the mechanism of
motion and how to control this.
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